Trial intelligence / Profile preview

Curcumin for Physical and Cognitive Function in Aging

NCT03085680Phase 3Completed

Sponsor
University of Florida
Start
Aug 2017
Primary completion
Oct 2019
Countries
1
01

Overview

Phase 3, randomised, double-blind trial (2 arms), sponsored by University of Florida. Primary endpoints: Change in walking speed at 3 months and Change in grip strength at 3 months. Started Aug 2017; status: completed.

Beyond the preview

Go deeper on NCT03085680.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03085680.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call